Mahazarin Ginwalla (@mahazaring) 's Twitter Profile
Mahazarin Ginwalla

@mahazaring

HF & Transplant Cardiologist @Sutter Health Bay Area, Palo Alto Medical Foundation; Wife & Mom of 2; Love the Outdoors!

ID: 907604636340715521

calendar_today12-09-2017 13:59:42

3,3K Tweet

815 Followers

348 Following

Gregg Fonarow MD (@gcfmd) 's Twitter Profile Photo

Optimal implementation of GDMT for HFrEF could save ~100,000 additional lives a year in the US Yet, inertia defeats the best intentions of clinicians and health systems with delays, gaps, variations, and inequitable use #HFWeek2023

Optimal implementation of GDMT for HFrEF could save ~100,000 additional lives a year in the US

Yet, inertia defeats the best intentions of clinicians and health systems with delays, gaps, variations, and inequitable use 

#HFWeek2023
Robert Mentz, MD (@robmentz) 's Twitter Profile Photo

Concern over AKI might stall effective HFrEF implementation Now at JCF: In >25,000 Medicare beneficiaries w HFrEF, hosp for AKI no different in those w de-novo ARNI vs. RASi initiation Ankeet S. Bhatt, MD, MBA Muthu Vaduganathan Rishi J Desai onlinejcf.com/article/S1071-…

Concern over AKI might stall effective HFrEF implementation
Now at JCF: In >25,000 Medicare beneficiaries w HFrEF, hosp for AKI no different in those w de-novo ARNI vs. RASi initiation
<a href="/ankeetbhatt/">Ankeet S. Bhatt, MD, MBA</a> <a href="/mvaduganathan/">Muthu Vaduganathan</a> <a href="/Rishidesai11/">Rishi J Desai</a> onlinejcf.com/article/S1071-…
Women in Heart Transplantation and MCS (@womenintxp_mcs) 's Twitter Profile Photo

Read our perspective on current crisis in #AHFTC led by #EmanHamad Shelley Hall Johanna Contreras, MD, MSc, FACC, FAHA, FHFSA Anju Bhardwaj MD FACC Journal of Cardiac Failure 🎯Practice Model, Compensation, Work life balance, curriculum reform & pathways & lack of exposure during Gen Cards need attention 👉 sciencedirect.com/science/articl…

BiykemBozkurt (@biykemb) 's Twitter Profile Photo

Differentiation between Worsening HF (Trajectory) and Decompensated HF(Threshold for escalated and rescue therapy). Also response to GDMT important Responsive to GDMT: Improving/in Remission Nonresponsive to GDMT: Persistent HF/ WHF JACC Journals #JACCHF jacc.org/doi/10.1016/j.…

Differentiation between Worsening HF (Trajectory) and Decompensated HF(Threshold for escalated and rescue therapy). Also response to GDMT important
Responsive to GDMT: Improving/in Remission
Nonresponsive to GDMT: Persistent HF/ WHF 
<a href="/JACCJournals/">JACC Journals</a> #JACCHF
jacc.org/doi/10.1016/j.…
Jacob Abraham, MD (@abraham_jacob) 's Twitter Profile Photo

A must-read for clinicians who treat HF🫀shock, emphasizing best practices: 🔑Early identification (often subtle in SCAI B) 🔑Hemodynamic profiling of shock with PAC 🔑 Hemodynamically-targeted therapy 🔑 Decongestion 🔑 Early MCS 🔗 bit.ly/3py8V1y

A must-read for clinicians who treat HF🫀shock,  emphasizing best practices:

🔑Early identification  (often subtle in SCAI B)
 🔑Hemodynamic profiling of shock with PAC
🔑 Hemodynamically-targeted therapy
🔑 Decongestion
🔑 Early MCS 
🔗 bit.ly/3py8V1y
M Velia Antonini (@foamecmo) 's Twitter Profile Photo

Heart #transplantation from DCD? Safe strategy to expand donor pool: outcomes noninferior vs DBD! 🏥 385 adult heart-only Tx (largest single-center study), Jan 2020-Jan 2023 🫀122 DCDD grafts, younger/fewer comorbidities vs DBD 🩸83% recovered with NRP 📉DCD recipients less

Heart #transplantation from DCD? Safe strategy to expand donor pool: outcomes noninferior vs DBD!
🏥 385 adult heart-only Tx (largest single-center study), Jan 2020-Jan 2023 
🫀122 DCDD grafts, younger/fewer comorbidities vs DBD
🩸83% recovered with NRP
📉DCD recipients less
Marta Farrero (@martafarrero) 's Twitter Profile Photo

Interested in tricuspid regurgitation and its cardiorenal consequences? Check out our new review! Thankful for this amazing team, turning challenges into opportunities. Proud of our HF fellows!!🔝🔝José Jesús Broseta Pedro Caravaca Pérez Ilana Forado @JGuzmanBofarull Diana Rodríguez Espinosa Yas Moayedi

Mahwash Kassi (@mahwash_kassi) 's Twitter Profile Photo

🔍 Exciting session on iron deficiency in Heart Failure! Key takeaways: 1️⃣ Check Fe studies: Tsat and Ferritin 2️⃣ Benefits irrespective of Hb 3️⃣ IV iron for replete iron stores only 4️⃣ Expect improved QOL, 6MWT, reduced hospitalizations, and CV mortality. #HFSA2023 Nosheen Reza, MD, MS

HFSA (@hfsa) 's Twitter Profile Photo

Today we honor the 2023 HFSA Lifetime Achievement Award winner Randall Starling, MD, MPH, FACC, FAHA, FESC, FHFSA! This award recognizes the significant and sustained contribution he has made to the field of heart failure. Congratulations 👏 Cleveland Clinic Cleveland Clinic Heart, Vascular & Thoracic #HFSA2023

Today we honor the 2023 HFSA Lifetime Achievement Award winner <a href="/rcstarling/">Randall Starling</a>, MD, MPH, FACC, FAHA, FESC, FHFSA! This award recognizes the significant and sustained contribution he has made to the field of heart failure. Congratulations 👏
<a href="/ClevelandClinic/">Cleveland Clinic</a> <a href="/CleClinicHVTI/">Cleveland Clinic Heart, Vascular & Thoracic</a> #HFSA2023
Arvind Bhimaraj (@hfdocbhimaraj) 's Twitter Profile Photo

#HFSA2023. Great panel discussion on Genetics and HF. Consider genetic testing and counseling for all Nonischemic patients. More to come for the future on understanding genetic underpinnings and hopefully genetic modulation therapy. Mahwash Kassi Kaitlyn Amos

Harriette Van Spall, MD MPH 🇨🇦 (@hvanspall) 's Twitter Profile Photo

Grateful for the opportunity to discuss the potential of #ArtificialIntelligence in #heartfailure HFSA -Many applications - Overlapping features w traditional statistics - Several limitations - Potential far from met Look forward to @mitchpsotka Jane Wilcox debate #HFSA2023

Grateful for the opportunity to discuss the potential of #ArtificialIntelligence in #heartfailure <a href="/HFSA/">HFSA</a>
-Many applications
- Overlapping features w traditional statistics
- Several limitations
- Potential far from met
Look forward to @mitchpsotka <a href="/janewilcox/">Jane Wilcox</a> debate #HFSA2023
Amin Yehya, MD, MS, FACC, FHFSA (@aminyehyamd) 's Twitter Profile Photo

Crowd cheering for the #SELECTTrial! Once weekly #semaglutide in patients with pre-existing CVD and overweight or obesity who don’t have diabetes reduced the risk of #cardiovascular death, MI, and non-fatal stroke by 20%, with NNT of 67! Super impressive findings #AHA23 #AHA2023

Crowd cheering for the #SELECTTrial! Once weekly #semaglutide in patients with pre-existing CVD and overweight or obesity who don’t have diabetes reduced the risk of #cardiovascular death, MI, and non-fatal stroke by 20%, with NNT of 67! Super impressive findings #AHA23 #AHA2023